Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Wash-sale considerations when replacing dividend ETF protect your tax position. This guide outlines rule basics, look-back periods, and compliant practices.
13,645 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
Firms across tech and logistics are testing cheaper Chinese AI models as U.S. rivals grow pricier. The move spans sta...
Interactive Brokers grew customer accounts by 34% in the last year, signaling strong momentum in a competitive discou...
The horizon ahead is dotted with questions about SoFi and its next investor update. This guide lays out a practical f...
A leading XRPL validator announced opposition to additional reserve reductions, reviving a divide in the community ov...
Premium cinema formats are drawing crowds and lifting ticket revenues, signaling a shift in consumer budgets and thea...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
Turn your know-how into steady income with a practical plan. This guide shows how to find your niche, price your offe...
A significant stake in Clearwater Analytics has sparked renewed interest in the company’s SaaS-driven investment acco...
Climate risk scores are moving from a niche risk tool to a gatekeeper in many loan deals. This article breaks down wh...
Bitcoin's Divergence From Nasdaq raises questions about dollar liquidity and credit conditions. This article breaks d...